# Perrigo Company plc (PRGO) FY2026 Q2 Revenue by Geography

- Company: Perrigo Company plc (PRGO)
- Statement: Perrigo Company plc (PRGO) FY2026 Q2 P&L / Income Statement, https://plicit.ai/financials/prgo/fy2026-q2-income-statement
- Period: 2026-03-29 to 2026-06-27
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001585364-26-000145
- Page: https://plicit.ai/financials/prgo/fy2026-q2-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/prgo-fy2026-q2-revenue-by-geography-sankey.png

## Chart details: Revenue by Geography

Income statement for 2026-03-29 through 2026-06-27. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 1,022,800,000 US dollars
- **Cost of sales**: 708,900,000 US dollars
- **Gross profit**: 313,900,000 US dollars
- **Total operating expenses**: 290,500,000 US dollars
- **Operating income (loss)**: 23,500,000 US dollars
- **Other income (expense), net (calculated)**: 81,900,000 US dollars
- **Income from continuing operations before taxes**: 105,400,000 US dollars
- **Income tax expense (benefit)**: 16,900,000 US dollars
- **Net income (loss)**: 74,500,000 US dollars
- **UNITED STATES**: 626,400,000 US dollars
- **Europe**: 371,700,000 US dollars
- **All other countries**: 24,700,000 US dollars
- **Impairment charges**: 1,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Other operating expense, net**: 0 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Research and development**: 23,700,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Distribution**: 21,700,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Restructuring**: 14,400,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Administration**: 100,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Selling**: 129,500,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Loss from discontinued operations, net of tax**: negative 14,100,000 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- The amounts that make up operating profit come to $23.40 M and operating profit is $23.50 M; the $0.10 M difference is within the rounding of the filed amounts.
- The amounts that make up net income come to $74.40 M and net income is $74.50 M; the $0.10 M difference is within the rounding of the filed amounts.

## Key Takeaways

- European sales fell 12% to $371.70 M, partly from the Dermacosmetics sale in April.
- US sales rose to $626.40 M from $610.90 M a year earlier, now 61% of Perrigo's total.
- Total sales fell 3.2% to $1.02 B, even though currency translation added $3.70 M.
- All other countries grew 4% to $24.70 M, too small to offset Europe's slide.

## The Unvarnished Truth

### Europe lost $50.00 M of Perrigo's sales while the US grew

Europe is where Perrigo's sales are leaking. Revenue there fell $50.00 M from a year earlier to $371.70 M, more than the company's total decline of $33.50 M, because US sales moved the other way. Part of the hole is self-inflicted: Perrigo sold its Dermacosmetics business, whose brands include ACO, Biodermal and Iwostin, on April 30, 2026, and management says that sale cut net sales by $23.6 million. The rest points to weaker demand, with management citing lower consumption across both the U.S. and Europe.

Why did the US grow while Europe shrank? US sales rose to $626.40 M from $610.90 M, a 2.5% gain after a 9.0% decline the quarter before. Europe's share of sales fell to 36% from 40%. Currency helped rather than hurt: favorable translation added $3.7 million to total net sales. Europe also felt a weaker cough and cold season, which left retailers holding less inventory. So Europe's slide is part portfolio choice and part soft demand, and the filing does not split the remainder between the two.

For investors, Perrigo is becoming more of an American company: the US brought in 61% of sales this quarter, up from 58% a year earlier. Its geography follows where the selling entity sits, not where the customer lives. A smaller Europe means less currency exposure but more dependence on US retailers, where management saw lower retailer inventory levels. Watch whether European consumption recovers once the divestiture laps. If Europe keeps shrinking after that, is Perrigo's international business still worth what the balance sheet says?

## Intelligent Insights for Investors

### Where in the world does Perrigo make its sales?

Mostly the US: $626.40 M of $1.02 B in sales this quarter came from there, with Europe the runner-up at $371.70 M. Perrigo assigns sales by the location of the entity that sells to a third party.

### Which regions drove the change in Perrigo's sales over the past year?

Europe alone: it lost $50.00 M from a year earlier, more than the $33.50 M fall in total revenue, because the US moved the other way.

## Intelligent Insights for Suppliers

### Which region lost the most ground for Perrigo over the past year?

Europe: its revenue fell 12% from a year earlier, while revenue as a whole fell 3.2%.
